Praveen Tyle - 05 Jan 2023 Form 4/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/Praveen Tyle, Ph.D.
Issuer symbol
SKYE
Transactions as of
05 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
09 Jan 2023, 10:28:00 UTC
Date Of Original Report
06 Jan 2023
Previous filing
03 Feb 2022
Next filing
07 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 05 Jan 2023 Common Stock 250,000 $0.0170 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 (the "Grant Date") and the options will vest in equal monthly installments over the one year period from December 8, 2022.